A#L06 #ACR23 @RheumNow Refractory juv SSc 6m-2y after autolog Stem Cell Tx - 5 patients HAQ VAS improved 75% (48-99%) All: mRSS MCID by 6 mo, 87% aver improvement, sustained at 2y GI: GIT mean 55% improvement, 1 unchanged FVC stable, DLCO improv >10% in 2, 5-10% in 2 #ACRBest https://t.co/cc6YToVEO5